The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"The Effect of Pharmacist-provided Non-dispensing Services On Patient Outcomes, Health Service Utilisation and Costs in Low- and Middle-income Countries: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433355/0/Iloprost_and_cisaprost_for_Raynaud's_phenomenon_in_progressive_systemic_sclerosis_Edited__no_change_to_conclusions_. Accessed 29 March 2024.
The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433355/0/Iloprost_and_cisaprost_for_Raynaud's_phenomenon_in_progressive_systemic_sclerosis_Edited__no_change_to_conclusions_. Accessed March 29, 2024.
The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433355/0/Iloprost_and_cisaprost_for_Raynaud's_phenomenon_in_progressive_systemic_sclerosis_Edited__no_change_to_conclusions_
The Effect of Pharmacist-provided Non-dispensing Services On Patient Outcomes, Health Service Utilisation and Costs in Low- and Middle-income Countries: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433355/0/Iloprost_and_cisaprost_for_Raynaud's_phenomenon_in_progressive_systemic_sclerosis_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries: Cochrane systematic review
ID - 433355
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433355/0/Iloprost_and_cisaprost_for_Raynaud's_phenomenon_in_progressive_systemic_sclerosis_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -